Vagelis E. Rinotas

Vari, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice.

Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice.

Journal: Frontiers in endocrinology

Published: January 08, 2026

RANKL Drives Bone Metastasis in Mammary Cancer: Protective Effects of Anti-Resorptive Treatments.

RANKL Drives Bone Metastasis in Mammary Cancer: Protective Effects of Anti-Resorptive Treatments.

Journal: International journal of molecular sciences

Published: April 25, 2025

Versican expression from lung fibroblasts suppresses pulmonary fibrosis.

Versican expression from lung fibroblasts suppresses pulmonary fibrosis.

Journal: Nature communications

Published: April 09, 2025

Prenatal Exposure to a Human Relevant Mixture of Endocrine-Disrupting Chemicals Affects Mandibular Development in Mice.

Prenatal Exposure to a Human Relevant Mixture of Endocrine-Disrupting Chemicals Affects Mandibular Development in Mice.

Journal: International journal of molecular sciences

Published: September 09, 2024

Interplay between bone marrow adiposity and bone resorption in RANKL-mediated modelled osteoporosis.

Interplay between bone marrow adiposity and bone resorption in RANKL-mediated modelled osteoporosis.

Journal: Journal of cellular physiology

Published: February 18, 2024

Cyld restrains the hyperactivation of synovial fibroblasts in inflammatory arthritis by regulating the TAK1/IKK2 signaling axis.

Cyld restrains the hyperactivation of synovial fibroblasts in inflammatory arthritis by regulating the TAK1/IKK2 signaling axis.

Journal: Cell death & disease

Published: February 07, 2024

Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics.

Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics.

Journal: Cancers

Published: July 16, 2023

Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors.

Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors.

Journal: International journal of molecular sciences

Published: June 22, 2023

Phosphotungstic acid-enhanced microcomputed tomography for quantitative visualization of mouse mammary gland morphology.

Phosphotungstic acid-enhanced microcomputed tomography for quantitative visualization of mouse mammary gland morphology.

Journal: Journal of medical imaging (Bellingham, Wash.)

Published: August 10, 2022

A20 controls RANK-dependent osteoclast formation and bone physiology.

A20 controls RANK-dependent osteoclast formation and bone physiology.

Journal: EMBO reports

Published: April 12, 2022

Proteomic Identification of the SLC25A46 Interactome in Transgenic Mice Expressing SLC25A46-FLAG.

Proteomic Identification of the SLC25A46 Interactome in Transgenic Mice Expressing SLC25A46-FLAG.

Journal: Journal of proteome research

Published: January 05, 2022

Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2.

Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2.

Journal: Antioxidants (Basel, Switzerland)

Published: December 06, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026